全文获取类型
收费全文 | 3790篇 |
免费 | 187篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 78篇 |
儿科学 | 78篇 |
妇产科学 | 84篇 |
基础医学 | 486篇 |
口腔科学 | 67篇 |
临床医学 | 357篇 |
内科学 | 970篇 |
皮肤病学 | 25篇 |
神经病学 | 605篇 |
特种医学 | 128篇 |
外科学 | 395篇 |
综合类 | 9篇 |
一般理论 | 2篇 |
预防医学 | 174篇 |
眼科学 | 37篇 |
药学 | 236篇 |
中国医学 | 15篇 |
肿瘤学 | 259篇 |
出版年
2024年 | 4篇 |
2023年 | 29篇 |
2022年 | 63篇 |
2021年 | 97篇 |
2020年 | 63篇 |
2019年 | 84篇 |
2018年 | 103篇 |
2017年 | 75篇 |
2016年 | 110篇 |
2015年 | 104篇 |
2014年 | 155篇 |
2013年 | 186篇 |
2012年 | 283篇 |
2011年 | 254篇 |
2010年 | 160篇 |
2009年 | 141篇 |
2008年 | 251篇 |
2007年 | 250篇 |
2006年 | 245篇 |
2005年 | 261篇 |
2004年 | 228篇 |
2003年 | 202篇 |
2002年 | 197篇 |
2001年 | 42篇 |
2000年 | 24篇 |
1999年 | 31篇 |
1998年 | 58篇 |
1997年 | 29篇 |
1996年 | 16篇 |
1995年 | 35篇 |
1994年 | 19篇 |
1993年 | 19篇 |
1992年 | 15篇 |
1991年 | 11篇 |
1990年 | 18篇 |
1989年 | 12篇 |
1988年 | 7篇 |
1987年 | 10篇 |
1986年 | 9篇 |
1985年 | 14篇 |
1984年 | 13篇 |
1983年 | 7篇 |
1982年 | 15篇 |
1981年 | 6篇 |
1980年 | 8篇 |
1979年 | 8篇 |
1978年 | 5篇 |
1974年 | 8篇 |
1973年 | 4篇 |
1970年 | 4篇 |
排序方式: 共有4005条查询结果,搜索用时 0 毫秒
71.
Marzocchi A Piovaccari G Manari A Aurier E Benassi A Saia F Casella G Varani E Santarelli A Guastaroba P Grilli R Maresta A 《The American journal of cardiology》2005,95(12):1409-1414
We evaluated the clinical effect of selective use of sirolimus-eluting stents (SESs) in real-world, high-risk patients. A total of 4,237 consecutive patients who underwent percutaneous coronary intervention (SES, n = 872, bare metal stents [BMSs], n = 3,365) was enrolled in a prospective regional survey. A prespecified high-risk subset of patients was selected on the basis of clinical and angiographic characteristics. A propensity score analysis was performed to compare patients who received SESs with those who received BMSs. Patients in the SES group more often had diabetes and more frequently had previous myocardial infarction or coronary revascularization, type C lesions, and multivessel procedures. Patients who presented with acute myocardial infarction were treated more often with BMSs. At 9 months, the use of SESs was associated with fewer major adverse cardiac events (death, myocardial infarction, or target lesion revascularization; hazard ratio 0.56, 95% confidence interval 0.37 to 0.85) and target lesion revascularizations (hazard ratio 0.43, 95% confidence interval 0.20 to 0.91). This decrease was more evident in a prespecified high-risk subgroup of patients (major adverse cardiac events, 8.0% SES vs 15.6% BMS, hazard ratio 0.45, 95% confidence interval 0.29 to 0.72). We conclude that selective SES use in real-world patients who have high-risk clinical and angiographic characteristics is associated with significant decreases in major adverse cardiac events and repeat revascularizations compared with BMS use. 相似文献
72.
Summary Clofibrate, 3g/die for 10 consecutive days, significantly reduced arginine-induced IRI release in chemical diabetics and in normal controls,
whether of normal body weight or obese. Blood glucose levels were not affected by clofibrate. In agreement with previous findings,
it would appear that clofibrate, administered for short periods, does not lead to a decrease in glucose tolerance. However,
studies relating to the effect of chronic clofibrate administration in chemical diabetes are needed in order to be sure that
prolonged inhibition of IRI secretion does not lead to overt diabetes. 相似文献
73.
Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction 总被引:11,自引:0,他引:11
Marenzi G Lauri G Assanelli E Campodonico J De Metrio M Marana I Grazi M Veglia F Bartorelli AL 《Journal of the American College of Cardiology》2004,44(9):1780-1785
OBJECTIVES: The aim of this research was to assess the incidence, clinical predictors, and outcome of contrast-induced nephropathy (CIN) after primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI). BACKGROUND: Contrast-induced nephropathy is associated with significant morbidity and mortality after PCI. Patients undergoing primary PCI may be at higher risk of CIN because of hemodynamic instability and unfeasibility of adequate prophylaxis. METHODS: In 208 consecutive AMI patients undergoing primary PCI, we measured serum creatinine concentration (Cr) at baseline and each day for the following three days. Contrast-induced nephropathy was defined as a rise in Cr >0.5 mg/dl. RESULTS: Overall, CIN occurred in 40 (19%) patients. Of the 160 patients with baseline Cr clearance >/=60 ml/min, only 21 (13%) developed CIN, whereas it occurred in 19 (40%) of those with Cr clearance <60 ml/min (p < 0.0001). In multivariate analysis, age >75 years (odds ratio [OR] 5.28, 95% confidence interval [CI] 1.98 to 14.05; p = 0.0009), anterior infarction (OR 2.17, 95% CI 0.88 to 5.34; p = 0.09), time-to-reperfusion >6 h (OR 2.51, 95% CI 1.01 to 6.16; p = 0.04), contrast agent volume >300 ml (OR 2.80, 95% CI 1.17 to 6.68; p = 0.02) and use of intraaortic balloon (OR 15.51, 95% CI 4.65 to 51.64; p < 0.0001) were independent correlates of CIN. Patients developing CIN had longer hospital stay (13 +/- 7 days vs. 8 +/- 3 days; p < 0.001), more complicated clinical course, and significantly higher mortality rate (31% vs. 0.6%; p < 0.001). CONCLUSIONS: Contrast-induced nephropathy frequently complicates primary PCI, even in patients with normal renal function. It is associated with higher in-hospital complication rate and mortality. Thus, preventive strategies are needed, particularly in high-risk patients. 相似文献
74.
75.
Carmen Barba Massimo Cossu Renzo Guerrini Giancarlo Di Gennaro Flavio Villani Luca De Palma Laura Grisotto Alessandro Consales Domenica Battaglia Nelia Zamponi Piergiorgio dOrio Martina Revay Michele Rizzi Sara Casciato Vincenzo Esposito Pier Paolo Quarato Roberta Di Giacomo Giuseppe Didato Chiara Pastori Giusy Carfi Pavia Simona Pellacani Giulia Matta Mattia Pacetti Gianpiero Tamburrini Elisabetta Cesaroni Gabriella Colicchio Giampaolo Vatti Sofia Asioli Massimo Caulo Carlo Efisio Marras Laura Tassi 《Epilepsia》2021,62(1):128-142
76.
Edoardo Conte Daniele Andreini Marco Magnoni Serge Masson Saima Mushtaq Sergio Berti Mauro Canestrari Giancarlo Casolo Domenico Gabrielli Roberto Latini Paolo Marraccini Tiziano Moccetti Maria Grazia Modena Gianluca Pontone Marco Gorini Aldo P. Maggioni Attilio Maseri 《Journal of Cardiovascular Computed Tomography》2021,15(1):73-80
BackgroundHigh-risk coronary atherosclerosis features evaluated coronary CT angiography (CCTA) were suggested to have a prognostic role. The present study aimed to evaluate the association of circulating biomarkers with high-risk plaque features assessed by CCTA.MethodsA consecutive cohort of subjects who underwent CCTA because of suspected CAD was screened for inclusion in the CAPIRE study. Based on risk factors (RF) burden patients were defined as having a low clinical risk (0–1 RF with the exclusion of patients with diabetes mellitus as single RF) or an high clinical risk (≥3 RFs). In all patients, measurement of inflammatory biomarkers and CCTA analysis focused on high-risk plaque features were performed. Univariate and multivariate logistic regression analysis were used to evaluate the relationship between clinical and biological variables with CCTA advanced plaque features.Results528 patients were enrolled in CAPIRE study. Older age and male sex appeared to be predictors of qualitative high-risk plaque features and associated with the presence of elevated total, non-calcified and low-attenuation plaque volume. Among circulating biomarkers only hs-CRP was found to be associated with qualitative high-risk plaque features (OR 2.02, p = 0.004 and 2.02, p = 0.012 for LAP and RI > 1.1, respectively) with borderline association with LAP-Vol (OR 1.52, p = 0.076); HbA1c and PTX-3 resulted to be significantly associated with quantitative high-risk plaque features (OR 1.71, p = 0.003 and 1.04, p = 0.002 for LAP-Vol, respectively).ConclusionsOur results support the association between inflammatory biomarkers (hs-CRP, PTX- 3), HbA1c and high-risk atherosclerotic features detected by CCTA. Male sex and older age are significant predictors of high-risk atherosclerosis. 相似文献
77.
Iván Cosamalón-Gan Tatiana Cosamalón-Gan Giancarlo Mattos-Piaggio Vega Villar-Suárez José García-Cosamalón José Antonio Vega-Álvarez 《Neurocirugía (Asturias, Spain)》2021,32(1):21-35
Up until fairly recently, it was thought that sciatic pain in the lumbar herniated disc was caused by compression on the nerve root. However, the lumbar herniated disc shows mixed pictures which are difficult to explain by simple mechanical compromise. In recent years various immunology, immunohistochemistry and molecular biology studies have shown that the herniated tissue is not an inert material, but rather it Is biologically very active with the capability of expressing a series of inflammatory mediators: cytokines such as interleukin-1, interleukin-6, interleuquin-8 and tumor necrosis factor being the ones which stand out. The inflammation is not only induced by the chemical irritation of the bioactive substances released by the nucleus pulposus but also by an autoimmune response against itself. Thus, in addition to the mechanical factor, the biomechanical mediation plays an important role in the pathophysiology of sciatic pain and of radiculopathy. Through a review of a wide range of literature, we researched the cellular molecular mediators involved in this inflammatory process around the lumbar herniated disc and its involvement in sciatic pain. 相似文献
78.
79.
80.
Paciocco G Uslenghi E Bianchi A Mazzarella G Roviaro GC Vecchi G Harari S 《Chest》2004,125(1):135-142
BACKGROUND: High-resolution CT (HRCT) scanning plays an important role in the diagnosis of diffuse cystic lung diseases (DCLDs). However, its role in the clinical evaluation of patients affected by DCLD has not yet been well-clarified. At present, pulmonary function tests are the only methods available for the evaluation of lung impairment due to these diseases, but their sensitivity and reliability are still limited. PURPOSE: The aim of this study was to correlate the quantitative score of cystic-aerial lesions obtained by a HRCT density mask (DM) software with pulmonary function data in DCLDs. METHODS: Spirometry, lung volumes, diffusion capacity, arterial blood gas (ABG) analysis, 6-min walking test (6-MWT), and HRCT with DM quantitative evaluation were performed in a cohort of 25 patients (lymphangioleiomyomatosis [LAM], 13 patients; Langerhans cells histiocytosis [LCH], 12 patients). Linear regression was used for the statistical analysis. The sum and mean of the air-trapping percentages at three different levels of DM study (ie, aortic arch, left lower lobe bronchus origin, and 2 cm from the diaphragmatic muscle), and various functional parameters and exercise performance values were matched for the analysis. RESULTS: An obstructive pattern was present in 13 patients (52%; LCH group, 8 patients; LAM group, 5 patients). A predominant restrictive pattern was detected only in three patients (12%; LCH group, two patients; LAM group, one patient). Nine patients (36%) walked < 350 m, and 14 of 23 patients (61%) had a significant decrease in arterial oxygen saturation during exercise (> 4 U). The results of DM quantitative study (sum and mean) significantly correlated with FVC (r = - 0.56; p < 0.001), FEV(1)/vital capacity (r = - 0.94; p < 0.002), midexpiratory phase of forced expiratory flow (r = - 0.84; p < 0.05), FEV(1) (r = - 0.82; p < 0.05), and diffusing capacity of the lung for carbon monoxide (r = - 0.82; p < 0.05), bronchial airway resistance (r = 0.79; p < 0.05), and distance walked on the 6-MWT (r = - 0.53; p < 0.05). No significant correlation was found with the results of ABG analysis. CONCLUSIONS: In DCLDs, HRCT scans with quantitative assessment performed by a DM software showed a very good correlation with functional parameters. Therefore, DM could be considered, in combination with a complete functional assessment, in the initial evaluation of patients affected by DCLDs. However, further studies are needed to assess its usefulness in the follow-up of these patients. 相似文献